Cabot Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Cabot ha aumentado sus beneficios a una tasa media anual de 28%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 13.9% anual. Los ingresos han ido creciendo a una tasa media de 7% al año. La rentabilidad financiera de Cabot es de 32.5%, y sus márgenes netos son de 11%.
Información clave
28.0%
Tasa de crecimiento de los beneficios
29.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.9% |
| Tasa de crecimiento de los ingresos | 7.0% |
| Rentabilidad financiera | 32.5% |
| Margen neto | 11.0% |
| Próxima actualización de resultados | 06 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
We Think Cabot (NYSE:CBT) Can Stay On Top Of Its Debt
Apr 09
Cabot Corporation's (NYSE:CBT) CEO Will Probably Have Their Compensation Approved By Shareholders
Mar 01We Ran A Stock Scan For Earnings Growth And Cabot (NYSE:CBT) Passed With Ease
Jan 29Cabot Corp.: Dividend Trends By The Numbers
Jan 18Investors Don't See Light At End Of Cabot Corporation's (NYSE:CBT) Tunnel
Jan 16Returns At Cabot (NYSE:CBT) Appear To Be Weighed Down
Jan 03Cabot (NYSE:CBT) Has A Somewhat Strained Balance Sheet
Dec 20Cabot Corporation: Undervalued Given Margin Expansion Execution
Oct 27Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Oct 18Do Cabot's (NYSE:CBT) Earnings Warrant Your Attention?
Oct 05Cabot (NYSE:CBT) Has Some Way To Go To Become A Multi-Bagger
Sep 22Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.12?
Sep 03Cabot (NYSE:CBT) Seems To Use Debt Quite Sensibly
Aug 13Cabot: The Low Upside Potential Discourages Purchases
Aug 10Is Now The Time To Put Cabot (NYSE:CBT) On Your Watchlist?
Jun 18Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.68?
Jun 03Cabot Corporation Can Grow With America
May 25Cabot (NYSE:CBT) Is Increasing Its Dividend To $0.40
May 11Does Cabot (NYSE:CBT) Have A Healthy Balance Sheet?
Apr 06Does Cabot (NYSE:CBT) Deserve A Spot On Your Watchlist?
Mar 10Cabot (NYSE:CBT) Is Very Good At Capital Allocation
Feb 24Cabot (NYSE:CBT) Has Affirmed Its Dividend Of $0.37
Feb 11Cabot Non-GAAP EPS of $0.98 misses by $0.01, revenue of $965M beats by $9.76M
Feb 09Is Cabot Corporation (NYSE:CBT) Potentially Undervalued?
Feb 01Cabot (NYSE:CBT) Is Due To Pay A Dividend Of $0.37
Jan 19Cabot Corporation: Continued Upside Exists, I Say 'Buy'
Jan 19Is Cabot (NYSE:CBT) A Risky Investment?
Dec 26Cabot (NYSE:CBT) Is Paying Out A Dividend Of $0.37
Nov 14An Intrinsic Calculation For Cabot Corporation (NYSE:CBT) Suggests It's 37% Undervalued
Nov 05Cabot Usually Rises On Q4 Earnings - Potential 40% Upside
Nov 04Cabot (NYSE:CBT) Knows How To Allocate Capital Effectively
Oct 18Cabot Corporation Is A Black Swan
Oct 04Is Cabot (NYSE:CBT) Using Too Much Debt?
Sep 08Cabot FQ3 2022 Earnings Preview
Aug 07Cabot: Massively Undervalued Chemicals For A Green World
Jul 19Investors Should Be Encouraged By Cabot's (NYSE:CBT) Returns On Capital
Jul 13Cabot declares $0.37 dividend
Jul 08Cabot declares $0.37 dividend
Jul 08Is Now The Time To Look At Buying Cabot Corporation (NYSE:CBT)?
Jun 25Are Investors Undervaluing Cabot Corporation (NYSE:CBT) By 39%?
Jun 06Cabot (NYSE:CBT) Seems To Use Debt Quite Sensibly
May 17Cabot Corporation: Excellent Performance, Good Future
May 12Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Cabot. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 3,924 | 433 | 260 | 59 |
| 30 Sep 23 | 3,931 | 437 | 253 | 57 |
| 30 Jun 23 | 4,078 | 300 | 242 | 57 |
| 31 Mar 23 | 4,259 | 315 | 237 | 58 |
| 31 Dec 22 | 4,318 | 348 | 246 | 55 |
| 30 Sep 22 | 4,321 | 206 | 257 | 55 |
| 30 Jun 22 | 4,113 | 142 | 290 | 56 |
| 31 Mar 22 | 3,881 | 130 | 306 | 56 |
| 31 Dec 21 | 3,631 | 98 | 297 | 55 |
| 30 Sep 21 | 3,409 | 247 | 293 | 56 |
| 30 Jun 21 | 3,164 | -54 | 315 | 57 |
| 31 Mar 21 | 2,765 | -144 | 296 | 54 |
| 31 Dec 20 | 2,633 | -219 | 292 | 57 |
| 30 Sep 20 | 2,614 | -238 | 295 | 57 |
| 30 Jun 20 | 2,782 | 65 | 246 | 54 |
| 31 Mar 20 | 3,109 | 103 | 261 | 57 |
| 31 Dec 19 | 3,243 | 127 | 268 | 58 |
| 30 Sep 19 | 3,337 | 155 | 270 | 60 |
| 30 Jun 19 | 3,360 | 217 | 281 | 65 |
| 31 Mar 19 | 3,369 | 273 | 282 | 66 |
| 31 Dec 18 | 3,343 | 77 | 295 | 67 |
| 30 Sep 18 | 3,242 | -114 | 295 | 66 |
| 30 Jun 18 | 3,115 | -136 | 282 | 64 |
| 31 Mar 18 | 2,966 | -177 | 279 | 61 |
| 31 Dec 17 | 2,826 | 69 | 263 | 59 |
| 30 Sep 17 | 2,717 | 246 | 258 | 57 |
| 30 Jun 17 | 2,613 | 225 | 270 | 53 |
| 31 Mar 17 | 2,529 | 234 | 269 | 51 |
| 31 Dec 16 | 2,419 | 209 | 264 | 49 |
| 30 Sep 16 | 2,411 | 145 | 266 | 48 |
| 30 Jun 16 | 2,463 | 136 | 251 | 49 |
| 31 Mar 16 | 2,536 | -366 | 256 | 52 |
| 31 Dec 15 | 2,662 | -388 | 263 | 54 |
| 30 Sep 15 | 2,871 | -336 | 271 | 58 |
| 30 Jun 15 | 3,111 | -348 | 281 | 58 |
| 31 Mar 15 | 3,357 | 150 | 290 | 58 |
| 31 Dec 14 | 3,561 | 160 | 303 | 60 |
| 30 Sep 14 | 3,647 | 195 | 309 | 60 |
| 30 Jun 14 | 3,632 | 214 | 304 | 65 |
| 31 Mar 14 | 3,593 | 219 | 300 | 66 |
| 31 Dec 13 | 3,534 | 212 | 296 | 65 |
| 30 Sep 13 | 3,456 | 153 | 290 | 68 |
| 30 Jun 13 | 3,408 | 142 | 286 | 68 |
Ingresos de calidad: CBT tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (11%) de CBT son superiores a los del año pasado (8.1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lCBT han crecido significativamente en un 28% al año.
Acelerando crecimiento: El crecimiento de los beneficios de CBT en el último año (24.4%) está por debajo de su media de 5 años (28% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de CBT en el último año (24.4%) superó al de la industria Chemicals -11.9%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (32.5%) de CBT se considera alta.